CeraVe Healing Ointment Skin Protectant, Non Greasy Feel, 3 Ounces

Description

Developed with dermatologists, CeraVe Healing Ointment Protects Dry Skin and provides intense, long-lasting moisturization to help soothe and relieve chapped and chafed skin. CeraVe Healing Ointment combines a non-greasy feel with skin identical ceramides. Suitable for use as an occlusive balm on extra-dry areas on the entire body, face, and even on dry, cracked hands Healing Ointment With ceramides 1, 3 and 6-II. Petrolatum (the active ingredient in healing ointments) comprises 46.5% of the formula Hyaluronic acid to help retain skin's moisture Non-comedogenic Lanolin-free Gentle, non-irritating formula Sensitive Friendly: identified by SkinSAFE as a product made without common allergens and irritants Dermatologist Tested: tested and approved by dermatologist for use on all types of skin   CeraVe Nighttime Slugging Routine: Step 1: Cleanse your face with CeraVe Hydrating Facial Cleanser Step 2: Moisturize your face with PM Moisturizing Lotion Step 3: Apply a thin layer of CeraVe Healing Ointment before bed to lock in moisture overnight 3-Step Slugging Routine (*After 1 week): Skin's overall appearance looks improved* Skin feels smoother* Skin feels softer* Skin feels deeply hydrated*   Brand Story: CeraVe is the #1 dermatologist recommended skincare brand*. Whether you need products for your sensitive, oily, acne-prone, combination or normal skin, need a soothing moisturizer for your baby, have specific skin concerns, like eczema or psoriasis, or just want a hydrating serum or anti-aging cream, CeraVe can help. The CeraVe story began in 2005 after experts noticed that many skin conditions such as acne, eczema, psoriasis and dry skin all had one thing in common: a compromised skin barrier. Developed with dermatologists, CeraVe offers a complete line of skincare products that contain three essential ceramides enhanced with a revolutionary delivery system to help restore the skin's natural protective barrier. *IQVIA, ProSource Survey, Q1-Q4 2020